These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22661428)

  • 1. Discovery of O-GlcNAc-modified proteins in published large-scale proteome data.
    Hahne H; Gholami AM; Kuster B
    Mol Cell Proteomics; 2012 Oct; 11(10):843-50. PubMed ID: 22661428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of O-GlcNAc-6-phosphate modified proteins in large-scale phosphoproteomics data.
    Hahne H; Kuster B
    Mol Cell Proteomics; 2012 Oct; 11(10):1063-9. PubMed ID: 22826440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications.
    Wells L; Vosseller K; Cole RN; Cronshaw JM; Matunis MJ; Hart GW
    Mol Cell Proteomics; 2002 Oct; 1(10):791-804. PubMed ID: 12438562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the major site of O-linked beta-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1.
    Ball LE; Berkaw MN; Buse MG
    Mol Cell Proteomics; 2006 Feb; 5(2):313-23. PubMed ID: 16244361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets.
    Alfaro JF; Gong CX; Monroe ME; Aldrich JT; Clauss TR; Purvine SO; Wang Z; Camp DG; Shabanowitz J; Stanley P; Hart GW; Hunt DF; Yang F; Smith RD
    Proc Natl Acad Sci U S A; 2012 May; 109(19):7280-5. PubMed ID: 22517741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-linked N-acetylglucosamine modification of insulin receptor substrate-1 occurs in close proximity to multiple SH2 domain binding motifs.
    Klein AL; Berkaw MN; Buse MG; Ball LE
    Mol Cell Proteomics; 2009 Dec; 8(12):2733-45. PubMed ID: 19671924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleocytoplasmic O-glycosylation: O-GlcNAc and functional proteomics.
    Vosseller K; Wells L; Hart GW
    Biochimie; 2001 Jul; 83(7):575-81. PubMed ID: 11522385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel strategy for global mapping of O-GlcNAc proteins and peptides using selective enzymatic deglycosylation, HILIC enrichment and mass spectrometry identification.
    Shen B; Zhang W; Shi Z; Tian F; Deng Y; Sun C; Wang G; Qin W; Qian X
    Talanta; 2017 Jul; 169():195-202. PubMed ID: 28411811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-N-Acetylglucosamine (O-GlcNAc) is a novel regulator of mitosis-specific phosphorylations on histone H3.
    Fong JJ; Nguyen BL; Bridger R; Medrano EE; Wells L; Pan S; Sifers RN
    J Biol Chem; 2012 Apr; 287(15):12195-203. PubMed ID: 22371497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome wide purification and identification of O-GlcNAc-modified proteins using click chemistry and mass spectrometry.
    Hahne H; Sobotzki N; Nyberg T; Helm D; Borodkin VS; van Aalten DM; Agnew B; Kuster B
    J Proteome Res; 2013 Feb; 12(2):927-36. PubMed ID: 23301498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc.
    Wells L; Vosseller K; Hart GW
    Science; 2001 Mar; 291(5512):2376-8. PubMed ID: 11269319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of O-linked N-acetylglucosamine (O-GlcNAc)-modified osteoblast proteins by electron transfer dissociation tandem mass spectrometry reveals proteins critical for bone formation.
    Nagel AK; Schilling M; Comte-Walters S; Berkaw MN; Ball LE
    Mol Cell Proteomics; 2013 Apr; 12(4):945-55. PubMed ID: 23443134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain.
    Khidekel N; Ficarro SB; Peters EC; Hsieh-Wilson LC
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13132-7. PubMed ID: 15340146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear and cytoplasmic glycosylation.
    Snow DM; Hart GW
    Int Rev Cytol; 1998; 181():43-74. PubMed ID: 9522455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification.
    Vosseller K; Sakabe K; Wells L; Hart GW
    Curr Opin Chem Biol; 2002 Dec; 6(6):851-7. PubMed ID: 12470741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global identification of O-GlcNAc-modified proteins.
    Nandi A; Sprung R; Barma DK; Zhao Y; Kim SC; Falck JR; Zhao Y
    Anal Chem; 2006 Jan; 78(2):452-8. PubMed ID: 16408927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel two-stage tandem mass spectrometry approach and scoring scheme for the identification of O-GlcNAc modified peptides.
    Hahne H; Kuster B
    J Am Soc Mass Spectrom; 2011 May; 22(5):931-42. PubMed ID: 21472528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry.
    Vosseller K; Trinidad JC; Chalkley RJ; Specht CG; Thalhammer A; Lynn AJ; Snedecor JO; Guan S; Medzihradszky KF; Maltby DA; Schoepfer R; Burlingame AL
    Mol Cell Proteomics; 2006 May; 5(5):923-34. PubMed ID: 16452088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Precise identification of
    Guo Z; Li H; Qin W
    Se Pu; 2021 Nov; 39(11):1182-1190. PubMed ID: 34677013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chemical approach for identifying O-GlcNAc-modified proteins in cells.
    Vocadlo DJ; Hang HC; Kim EJ; Hanover JA; Bertozzi CR
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9116-21. PubMed ID: 12874386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.